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Abstract
Cellular permissiveness to HIV infection is highly heterogeneous across individuals. Hetero-
geneity is also found across CD4+ T cells from the same individual, where only a fraction of
cells gets infected. To explore the basis of permissiveness, we performed single-cell RNA-
seq analysis of non-infected CD4+ T cells from high and low permissive individuals. Tran-
scriptional heterogeneity translated in a continuum of cell states, driven by T-cell receptor-
mediated cell activation and was strongly linked to permissiveness. Proteins expressed at
the cell surface and displaying the highest correlation with T cell activation were tested as bio-
markers of cellular permissiveness to HIV. FACS sorting using antibodies against several
biomarkers of permissiveness led to an increase of HIV cellular infection rates. Top candidate
biomarkers included CD25, a canonical activation marker. The combination of CD25 high
expression with other candidate biomarkers led to the identification of CD298, CD63 and
CD317 as the best biomarkers for permissiveness. CD25highCD298highCD63highCD317high
cell population showed an enrichment of HIV-infection of up to 28 fold as compared to the
unsorted cell population. The purified hyper-permissive cell subpopulation was characterized
by a downregulation of interferon-induced genes and several known restriction factors.
Single-cell RNA-seq analysis coupled with functional characterization of cell biomarkers pro-
vides signatures of the “HIV-permissive cell”.
Author summary
CD4+ T cells are the main target of human immunodeficiency virus (HIV) infection.
However, CD4+ T cells are not equally permissive to infection, varying between individu-
als and across cells isolated from the same individual. We explored cellular heterogeneity
by analyzing the transcriptome profile of CD4+ T cells at single-cell level. Results identi-
fied T-cell receptor-mediated activation as the major determinant of CD4+ T cell hetero-
geneity. We identified cell surface proteins that highly correlated with T cell activation
and HIV permissiveness. Activated CD4+ T cells expressing CD25, CD298, CD63 and
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CD317 were highly enriched for HIV permissiveness. The single-cell analysis approach
used in this study allowed for the identification of the most HIV-permissive cell.
Introduction
In vivo and in vitro data indicates that only a small fraction of the CD4+ T cell population is
successfully infected by HIV. Cellular permissiveness to HIV infection differs between cell
lines originating from different tissues, between T cell lines [1], between primary CD4+ T cells
isolated from different HIV-negative blood donors [2], as well as between primary CD4+ T
cells from the same donor [3]. HIV permissiveness in primary CD4+ T cells has been linked to:
(i) activation, i.e. proliferating activated CD4+ T lymphocytes are more susceptible to HIV
infection compared to resting CD4+ T cells [4–8]; (ii) specific CD4+ T cells subsets, such as
effector memory cells [8, 9] or specifically, CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T cells
[10]; and (iii) expression of specific HIV dependent/restriction cellular factors that can modu-
late HIV replication [3]. Differences in permissiveness in human cell lines was recently associ-
ated with transcriptional and functional defects in key components of innate immunity [1].
Nevertheless, the specific phenotypic and functional characteristics of primary CD4+ T cells
that are permissive to HIV infection remain elusive.
Single-cell technology is a valuable tool to study cellular heterogeneity in different biological
settings, including virology [11–13]. Single-cell sequencing permits to explore whether inter-
individual differences in successful infection can result from within-individual heterogeneity
across individual cells. Cellular heterogeneity within an individual can arise from the presence
of different subsets of CD4+ T cells [14, 15], differences in response to TCR activation [16], or
other determinants such as the expression of innate immunity genes [17–20]. This suggests a
model where a highly permissive individual possesses CD4+ T cells that are enriched in a given
cell lineage, activate more rapidly or differently, express less antiviral factors, or a combination
of factors.
Heterogeneity at the cellular level can result from differences in cell fate, i.e. permanent and
irreversible commitment to a lineage, or in cell state, resulting from transient and reversible
processes. Cell fate heterogeneity can lead to a mixture of cells of different types. Cell state dif-
ferences arise from the intermediate stages of differentiation or activation of a cell type, or
from stochasticity of gene expression, cell cycle, pulsating expression, circadian rhythms or
level of reactivity to stimuli [21]. There is also increasing attention to the possibility of monoal-
lelic expression, determining the use of different haplotypes in a given moment [22, 23].
Microfluidic control of cell capture and preparation of RNA-seq libraries from single cells
allows the study of transcriptional heterogeneity in a reliable way. This methodology was suc-
cessfully used to identify subpopulations and identify markers from many cell types [24–26].
The aim of this study was to use a non a priori and single-cell approach to identify molecu-
lar features that characterize the CD4+ T cell population most permissive to HIV infection. We
hypothesized that permissiveness could be a feature of a specific cell lineage(s) (cell fate), or a
feature of cells in a particular state. To this end, we performed comparative single-cell RNA-
seq analyses and large-scale immunoprofiling on non-infected CD4+ T cells from uninfected
individuals with extreme phenotypes of susceptibility to in vitro HIV infection. We showed
that cellular activation state (degree of response to TCR stimulation) was the main factor of
transcriptional heterogeneity at single cell level, which in turn translated in varying degrees of
HIV permissiveness. Importantly, the permissive cell was identified before infection, thus
revealing the biological basis of baseline CD4+ T cell susceptibility to HIV. Moreover, this
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single-cell based approach allowed the identification of specific biomarkers that partition cell
populations into high and low permissive subsets. The combination of multiple candidate bio-
markers further selected for highly permissive cells, thus defining the “HIV-permissive cell”.
Results
Single-cell RNA-seq analysis of CD4+ T cells from high and low HIV
permissiveness donors identifies T cell activation as the major driver of
transcriptional heterogeneity
To explore the basis of permissiveness in primary CD4+ T cells at a single-cell level we took
advantage of a previous study where a panel of donors was characterized for their heteroge-
neous permissiveness to HIV infection [3]. Cells from 18 donors were TCR-activated in pres-
ence of IL-2 for three days and evaluated for their cell growth and permissiveness using
VSV-G-pseudotyped eGFP expressing HIV-based vector (named HIV-GFP, S1 Fig). Two
donors, “42” and “123”, were selected as displaying different levels of permissiveness (high and
low permissive with ~40% and ~10% GFP+ infected cells, respectively), while showing similar
growth capacity (Fig 1A and S1 Fig).
To investigate cell heterogeneity without a priori, uninfected CD4+ T cells from the selected
donors were used for single-cell RNA-seq analysis using Fluidigm C1 technology. This tech-
nology is based on a microfluidic device that uses pre-defined plates based on cell size to sepa-
rate single cells. To isolate activated CD4+ T cells, we used the medium size chip that can
accommodate cells ranging from 10 to 17 μm (± 2 μm). Although the use of pre-specified size
might introduce a bias, it more likely minimizes the difference between the two donors. Popu-
lation RNA sequencing was performed in parallel on bulk cell preparations. The transcrip-
tomes of 85 and 81 individual cells from the high and from the low permissive donor,
respectively, were profiled. An average of 25 million reads per cell was obtained. Of these, an
average of 6.6 million (standard deviation 2.7 million) paired reads (fragments) per cell was
uniquely mapped. Average gene expression levels across individual cells from the same donor
showed high correlation with the expression levels assessed on the equivalent bulk cell samples
sequenced by population RNA-seq (r = 0.78 and 0.77 for the high and low permissive donor,
respectively). Such high correlations served as a quality control of the overall single-cell
sequencing procedure. The pairwise comparisons among all individual cells from the same
individual showed a distribution of Spearman rank correlations of gene expression levels with
median of 0.72 and 0.58 for the high and low permissive donor, respectively, indicating that
transcriptional profiles of individual cells from the low permissive donor were more heteroge-
neous than those of the high permissive donor (Wilcoxon-rank sum test p-value < 2.2e-16;
S2 Fig).
We then explored transcriptional heterogeneity by Sincell software for the statistical assess-
ment of cell-state hierarchies developed in our laboratory [27]. The analysis showed a contin-
uum of transcriptional cell state for both donors, without branching patterns (S3 Fig). This
continuum was also observed in the Principal Component Analysis (PCA) of the single-cell
libraries from the donors, together with RNA-seq libraries from reference bulk cell samples
(resting CD4+ T cells and activated CD4+ T cells at 8h, 24h and 72h after TCR stimulation)
(Fig 1B). The two main principal axes–PC1 and PC2- explained 18.5% and 5.4% of the total
variance, respectively. PC1 presumably gathered heterogeneity related to the experimental
protocol (single-cell versus bulk sequencing). PC2 ordered bulk cell samples most likely
according to activation state, following time after TCR-mediated activation (resting, 8h, 24h
and 72h), and supported by Pearson correlation with the prototypical activation markers
CD25 (r = 0.562 with PC2, while r = 0.089 with PC1). Equivalent PCA analysis of the single-
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cell transcriptomes without considering the bulk samples confirmed this result (S4 Fig), with
the main principal axis of single individual cells (PC1, S4A Fig) highly correlating with PC2
axis of bulk population (S4B Fig, Pearson r = 0.9994). The distribution of individual cells along
PC2 showed that most of the cells from the high permissive donor had a transcriptional state
closer to a full activation state (Fig 1B, black dots). In contrast, individual cells from the low
permissive donor showed higher heterogeneity along this axis (Fig 1B, red dots) with tran-
scriptional states spreading between resting and 72h-activated bulk cell samples. These data
are consistent with activation bringing the cells toward a permissive phenotype. Cells from the
high permissive donor are more homogenous towards the permissive phenotype, while cells
Fig 1. Single-cell transcriptome analysis of low and high permissive TCR-activated CD4+ T cells. (A)
Susceptibility to HIV-GFP infection of cells isolated from a donor with high permissive cells (#42) and from a
donor with low permissive cells (#123). FACS plot analysis shows forward scatter plot (FSC) on the y axis and
GFP expression on the x axis. The region delineates GFP+ infected cells and the proportion of GFP+ cells is
indicated. (B) Principal Component Analysis (PCA) of single-cells (dots) from the high permissive (black) and
low permissive (red) donors as comparison to bulk populations (triangles). Bulk sequencing was performed
from cells collected at resting (pink), and after TCR activation (8h, 24h and 72h post-activation, purple). PCA
was performed on gene expression levels expressed as the log10 of the number of library size-normalized
reads per kilobase of exonic sequence (Methods).
https://doi.org/10.1371/journal.ppat.1006678.g001
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from the low permissive donor are more heterogeneous, with fewer cells that display the per-
missive phenotype. These data highlight the importance of single-cell approaches to investigate
heterogeneity that are otherwise masked by bulk population analyses, as shown by the proxim-
ity of the two donor populations at 72h. We also used a supervised approach to evaluate the
presence of different cell lineages by examining the expression of 63 genes broadly used to clas-
sify CD4+ T cell subpopulations (S5A Fig and S1 Table), including helper (Th1, Th2, Th17),
regulatory (T-reg), and memory (Effector and Central memory) CD4+ T cells. Clustering of
cells according to these markers did not show a clear patterning. Similar analysis was also per-
formed with 1503 innate immunity genes [19] that led to no obvious clustering of cellular sub-
populations (S5B Fig).
In summary, the unsupervised whole transcriptome PCA analysis and the supervised clus-
tering using prototypical CD4+ T cell markers and innate immunity genes identified T cell
activation as the major driver of cell heterogeneity and failed to identify the presence of
distinct lineages of T cell subtypes in the samples. This opened the door to hypothesize that
the cellular state, rather than cell fate and lineage, is the most significant contributor to
permissiveness.
Identification of cellular surface proteins as candidate markers for HIV
permissiveness
To identify protein biomarkers that would help sort and characterize the most permissive
cells, we explored the hypothesis of T cell activation having a major role in HIV permissive-
ness. For this, we focused on genes coding for cell-surface proteins and whose RNA expression
levels across single cells correlated with cell activation (PC2 axis, Fig 1B), and tested whether
their protein levels at single-cell level associated with permissiveness to HIV (Fig 2). FACS
analysis was used to investigate at single-cell resolution the expression level of surface proteins
in activated CD4+ T cells and assessed how they associated with successful HIV infection as
determined by GFP. This was accomplished with a large-scale surface molecule antibodies
screening (Fig 2A, upper panel). Forty-eight hours after activation, CD4+ T cells from the orig-
inal high permissive donor (donor #42) were infected with HIV-GFP and 24h later, a panel of
332 PE-conjugated antibodies (LEGENDScreen Human Cell Screening, BioLegend) was used
to investigate by FACS the co-occurrence of cell surface proteins and successful infection
(Fig 2A).
We assessed the Spearman rank correlation between each surface protein expression and
GFP levels in each individual cell (S2 Table). These correlation values reflect the association of
the marker with the cell permissiveness to productive HIV infection. We then determined the
level of association of these genes to activation using single-cell RNA-seq data (PC2 in Fig 1B
and S2 Table). Fig 2B shows that the candidate markers with the highest association with HIV
permissiveness are also the ones with the highest association with activation state. Moreover,
these results show that the main source of transcriptional heterogeneity across single-cells (as
captured by the activation state in the second principal component from Fig 1B) drives HIV
susceptibility as measured by the correlation of protein marker levels with GFP (adjusted R-
squared: 0.20; p-value = 9.7e-16).
From this correlation analysis we selected 14 candidate markers: CD63, CD317, CD25,
CD58, CD74, CD48, CD71, CD28, CD26, CD2, TIM3, CD298, CD253 and CD3; whose
expression highly correlated with both T cell activation and HIV permissiveness
(correlation 0.3 in both analyses and correlation 0.5 at least in one of the analyses, Fig
2B). The list includes, as expected, CD25 (IL-2 receptor), a canonical activation marker [28]
associated with susceptibility to HIV [29–31]. The correlation between marker expression and
Identification of the HIV permissive cell
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Fig 2. Screening for cellular markers of HIV permissiveness and CD4+ T cell activation. (A) Schematic
representation of experimental procedure: CD4+ T cells were TCR-stimulated for 48h and transduced with
HIV-GFP. After 24h, cells were stained with 332 PE-conjugated antibodies (LEGENDScreen) and analysed
by FACS to evaluate the expression of each marker, as well as GFP expression (as a surrogate of successful
viral infection). HIV permissiveness, i.e. GFP expression, was compared between cells expressing high levels
of candidate marker (MRK+, red) and low levels of candidate marker (MRK-, grey). In the top example, the
Identification of the HIV permissive cell
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HIV permissiveness was further validated in CD4+ T cells from four independent blood
donors (Fig 2C). With the exception of CD253, expression of each candidate marker was cor-
related with permissive status of cells.
CD4+ T cell sorting by selected markers prior to infection confirm their
role as biomarkers for HIV permissiveness
To determine if the selected candidate proteins were predictive markers for HIV permissive-
ness, it was important to exclude that the association observed between the candidate markers
and HIV permissiveness was not due to HIV infection per se. In fact, viral infection modulates
expression of many cellular genes [2]. Moreover, marker expression (i.e. Mean Fluorescence
Intensity (MFI) assessed by FACS) is often shifted or increased in the GFP+ population as
compared to the GFP- population (S6 Fig).
Therefore, activated CD4+ T cells were first sorted according to the expression of each can-
didate biomarker and then infected with HIV-GFP (Fig 3A). Sorting was performed based on
MFI expression (high vs low) rather than the proportion of cells expressing or not the marker
(+ versus -) (S7 Fig), as some of the selected markers were always present in CD4+ T cells while
their MFI could change over time (CD48, CD2, CD298 and CD3; S8 Fig). As depicted in Fig
3B, marker-high populations were always more permissive than marker-low populations for
all tested candidate biomarkers, except for CD74 which performed poorly for sorting and
which was thus discarded from further experiments. Sorting based on CD137 protein expres-
sion was used as control and data showed a similar permissiveness to HIV infection between
CD137high and CD137low populations.
Identified biomarkers expression increase permissiveness in CD25 high-
expressing cells
As CD25 is a strong activation marker, it might explain the whole phenotype of permissiveness
[31]. In order to investigate the possible involvement of additional biomarkers, we first
assessed how CD25 co-expressed with the other 11 biomarkers (S9 Fig) and whether these
markers were able to further enrich for permissive cells in CD4+ T cells positive for CD25. To
this end, TCR-stimulated CD4+ T cells were first sorted for CD25high regardless of the presence
or the absence of other markers (MRK), yielding a purified CD25high CD4+ T cell population.
This population was then further sorted for each of the other 11 markers to obtain cells
CD25highMRKlow and CD25highMRKhigh. The different populations were then infected with
HIV-GFP and analyzed by FACS, 48h post-infection (Fig 4A).
proportion of GFP+ cells was enriched in the MRK+ cell population; this candidate marker was thus positively
correlated with HIV permissiveness. In contrast, the example of the bottom panel showed that the proportion
of GFP+ cells was similar in both MRK+ and MRK- cell populations, suggesting a poor correlation between
marker expression and HIV permissiveness. (B) Correlation between single-cell transcriptome analysis and
cell surface protein expression screen. From single-cell RNA-seq, a correlation was performed between the
mRNA expression and cell activation for each candidate marker (y-axis). In parallel, the antibody screen
allowed to correlate marker expression with HIV permissiveness (x-axis). Correlation between these two
analyses (adjusted R-squared: 0.20; p-value = 9.7e-16) allowed to identify markers associated with HIV
permissiveness and activation. Top candidate markers are highlighted in red. (C) Validation of top candidates
as markers of HIV permissiveness. Activated CD4+ T cells were transduced with HIV-GFP and after 24h, GFP
and marker expression was measured by FACS. Values correspond to proportion of GFP expressing cells
and are normalized to one in the unsorted population (dash line; % of unsorted cell population between
8–20%). The proportion of GFP expressing cells was then assessed in both, MRK+ (red) and MRK- (grey),
gated subpopulations. Error bars indicate SEM and data shown are from 4 independent experiments with 4
different donors. ** corresponds to P<0.01; *** corresponds to P<0.001, from a paired t-test.
https://doi.org/10.1371/journal.ppat.1006678.g002
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Fig 3. HIV permissiveness of cell populations expressing high and low levels of the selected markers. (A)
Schematic representation of experimental procedure: CD4+ T cells were TCR-stimulated for 48h and FACS-sorted for each
single marker in two populations, expressing high or low levels of the markers. These populations were then transduced with
HIV-GFP and 48h post-transduction, GFP expression was evaluated by FACS. (B) HIV permissiveness in FACS sorted
populations. Values correspond to GFP (%) fold increase in the high marker population (in red) and in the low marker
population (in grey), as compared to unsorted population (dash line; % of unsorted cell population between 30–50%). Error
bars indicate SEM and data shown is from 4 independent experiments with 4 different donors. ** corresponds to P<0.01,
*** corresponds to P<0.001, from a paired t-test.
https://doi.org/10.1371/journal.ppat.1006678.g003
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Fig 4. HIV permissiveness of CD25highCD4+ T cells expressing an additional candidate biomarker. (A)
Schematic representation of experimental procedure: CD4+ T cells were TCR-stimulated for 48h and FACS
sorted first for CD25 (high and low) and then the CD25high population was further sorted for the expression of each
of the other candidate markers (high expression versus low expression). These populations were then transduced
with HIV-GFP and 48h post-transduction, GFP expression was evaluated by FACS. Gating for sorting of high and
low expressing populations was always defined from the initial unsorted cell population. (B) HIV permissiveness
in FACS sorted populations. The graph shows the permissiveness of the sorted population (fold increase from
unsorted population). Sorted populations were CD25low (light blue), CD25high (dark blue), CD25highMRKlow (light
red) and CD25highMRKhigh (dark red). Values correspond to GFP (%) fold increase as compared to unsorted
population (grey bar; unsorted population between 13–32% of GFP positive cells). Error bars indicate SEM and
data shown is from 4 independent experiments with 4 different donors. * corresponds to P<0.05, ** corresponds
to P<0.01, *** corresponds to P<0.001, from a paired t-test.
https://doi.org/10.1371/journal.ppat.1006678.g004
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As expected, sorting by CD25high enriched for cells permissive to HIV as compared to
CD25low and unsorted populations (2.4 fold and 1.6 fold, respectively). The CD25high popula-
tion can be further separated according to high and low expression level of additional markers,
displaying further increased and decreased permissiveness, respectively. Indeed, use of addi-
tional markers in sorting resulted in CD25highMRKhigh populations that increased the permis-
siveness to HIV as compared to CD25highMRKlow (ranging from 4.3 fold to 1.5 fold),
confirming that all 11 markers contribute in addition to CD25 to further enrich for cells per-
missive to HIV (Fig 4B). Further evaluation showed that the increase in permissiveness to HIV
observed in CD25highMRKhigh populations as compared to CD25high was also statistically sig-
nificant for 8 out of the 11 candidates (S3 Table and S10 Fig).
Three markers, CD298, CD63 and CD317, with 2.2, 2.3 and 2.0 fold increase of permissive
cells compared to unsorted cells, and 1.4, 1.5 and 1.3 fold compared to CD25high cells, respec-
tively, were selected for further analyses. Expression of these markers in different CD4+ T cells
subsets, i.e. naïve versus memory cells 48h post-TCR stimulation, showed similar profiles, sug-
gesting that the association of these markers with HIV permissiveness remains valid across cell
lineages (S11 Fig).
Combination of activation markers leads to an increase of HIV
permissive cells
We tested the additive contribution of the 4 biomarkers, CD25, CD298, CD63 and CD317,
to identify highly permissive cells. While the 4 markers generally co-express two by
two (S12A Fig), only ~20% of activated CD4+ T cells highly co-express the 4 markers
simultaneously (S12B Fig). These results led us to proceed with the sorting of the CD25high
CD298highCD63highCD317high population, where TCR-activated CD4+ T cells were sorted
successively for high expression of CD25, CD298, CD63 and CD317 cells and then infected
with HIV-GFP (EF1-GFP). As shown in Fig 5A, the progressive addition of markers
increased in a statistically significant manner the amount of permissive cells with an increase
of 28 fold from the unsorted population to the four marker combination (S4 Table and S13
Fig). The role of these markers to HIV permissiveness was confirmed with a full-length, rep-
lication-competent CXCR4-tropic virus expressing GFP (NLENG1), entering the cells via
CXCR4-mediated entry rather than VSV-G (Fig 5B). Activated CD4+ T cells, from different
donors, infected with NLENG1 showed a statistically significant increase of permissiveness
to HIV infection up to 5.4 fold with the four markers (Fig 5B, S4 Table and S13 Fig). Taken
together, these results indicate that the initial selected markers, CD25, CD298, CD63 and
CD317, whose expression was associated with activation at single-cell level both at mRNA
and protein levels, identify highly permissive cells. These cells are characterized by an intra-
cellular environment supportive of HIV infection, from entry to protein expression. Due to
technical limitations and increasing rarity of specific cell subpopulations, our analyses con-
centrated on 4 selected markers. However, the use of additional candidate markers should
further improve the selection of the highest permissive cell (S14 Fig).
Transcriptional features of HIV permissive cells
The availability of novel markers allowed the sorting of a unique cell subpopulation for charac-
terization of the transcriptome. RNA was extracted from the sorted subpopulations according
to MRK expression and used for RNA-Seq. Principal Component Analysis showed separation
and ordering of cell subpopulations according to their permissiveness to HIV infection, i.e.
from less to more permissive: CD25low, CD25highMRK3low
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(CD25highCD298lowCD63lowCD317low), CD25high and CD25highMRK3high (CD25high
CD298highCD63highCD317high) (Fig 6A).
Differential expression analyses among sorted CD25high and CD25highMRK3high subpopu-
lations identified 96 genes (fold change higher or lower than 2 and adjusted p-value
of< 0.001; DESeq2 test [32]), that could be involved in the observed differences in HIV per-
missiveness. 95 genes were differentially downregulated in CD25highMRK3high as compared to
CD25high (Fig 6B and S5 Table). Functional enrichment analysis established that downregu-
lated genes were in the type I interferon pathway (GO:0060337, False Discovery Rate 4.17e-06)
and the defense response to virus (GO.0051607, FDR = 1.32e-04) (S6 Table). Genes involved
included important effectors such as: IFIT2, IFIT3, IRF7, ISG15, ISG20, MX1, RSAD2, XAF1,
IFI44L, and IL23A. In sharp contrast, the 95 genes appeared as highly expressed in both
CD25low and CD25highMRK3low subpopulations. These observations further stress the rela-
tionship between activation state and innate immunity defense, in line with recent work [1].
Although not among the 96 genes differentially expressed between sorted CD25high and
CD25highMRK3high populations (fold change higher or lower than 2 and adjusted p-value
of< 0.001), the expression profile of the 5 prototypical HIV restriction factors still clustered
the subpopulations similarly, i.e. according to the permissiveness phenotype (S15 Fig).
Discussion
CD4+ T cells are the main target of HIV infection and the major cellular reservoirs of HIV in
vivo. Understanding the heterogeneity of these cells in terms of permissiveness to HIV is cru-
cial for the characterization of HIV infection and pathogenesis. In this study, we exploited the
natural heterogeneity within and across individuals to explore differences between permissive
Fig 5. HIV permissiveness of CD4+ T cells highly expressing the top candidate biomarkers. CD4+ T cells were TCR-
stimulated for 48h and FACS sorted sequentially for CD25high, CD298high, CD63high and CD317high. The sorted populations were
then transduced with HIV-GFP (EF1-GFP) (A) or the replication competent HIV virus expressing GFP (NLENG1) (B) Values
correspond to GFP (%) fold increase as compared to unsorted population (unsorted population between 1–5% of GFP positive cells
for HIV-GFP and 5–30% of positive cells for NLENG1). Error bars indicate SEM and data shown is from 4 independent experiments
with 4 different donors in A and 5 independent experiments with 5 different donors in B. Statistical significance of the effect on the
fold-increase of permissive cells compared to unsorted cells as a function of the number of additional activation markers used on top
of CD25high was evaluated in S4 Table using a linear regression model and led to significant p-values in both experiments (p-
value<5e-03).
https://doi.org/10.1371/journal.ppat.1006678.g005
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and non-permissive cells by single-cell RNA-seq. This approach allowed the characterization
of response to TCR activation as the main driver of heterogeneity. Moreover, coupling single-
cell RNA-seq analysis with a high-throughput antibody screen for cell surface protein expres-
sion led to the identification of biomarkers for the HIV permissive cell.
The analysis of single-cell RNA-seq allowed assessing the dynamic nature of TCR activa-
tion. We observed a continuum of individual cells transiting intermediary activation states
that recapitulated transcriptional changes occurring from resting CD4+ T cells to late times of
activation. We then identified sets of genes reflecting such heterogeneity. Supervised analyses
of RNA-seq levels of cell surface markers prototypical of CD4+ T cell subpopulations as well as
of innate immunity genes did not make apparent the existence of distinct lineages of cells.
Taken together, our results indicate that the activation state was the main component of CD4+
T cell transcriptional heterogeneity.
Activation state of CD4+ T cells has been extensively linked to HIV permissiveness in popu-
lation, bulk samples. It is well known that quiescent cells are refractory to HIV infection [5,
Fig 6. Transcriptome analysis of sorted subpopulations of bulk CD4+ T cells. (A) Principal Component Analysis of cell subpopulations of bulk
CD4+ T cells at 48h after activation FACS sorted for: CD25low, CD25highMRK3low (CD25highCD298lowCD63lowCD317low), CD25high and
CD25highMRK3high (CD25highCD298highCD63highCD317high). The unsorted reference bulks are also included. PC1 placed samples according to their
permissiveness to HIV infection from left (low permissive) to right (high permissive). (B) Heatmap clustering of the 96 genes differentially expressed
among sorted CD25high and CD25highMRK3high (fold change higher or lower than 2 and adjusted p-value of < 0.001; DESeq2 test [32]). Complete
hierarchical clustering of genes and cell samples was based on Pearson correlation. Color scale indicated in the legend corresponds to z-scores of
gene expression levels expressed as the log10 of the number of library size-normalized reads per kilobase of exonic sequence, ranging from green
(low) to red (high) expression. Downregulated genes are enriched in the type I interferon pathway (GO:0060337) and the defense response to virus
(GO.0051607; S5 Table), and include important effectors such as: IFIT2, IFIT3, IRF7, ISG15, ISG20, MX1, RSAD2, XAF1, IFI44L and IL23A.
https://doi.org/10.1371/journal.ppat.1006678.g006
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33]. Here, we have further associated activation and permissiveness at single cell resolution
characterizing both phenotypes at transcriptional and proteomic levels. In addition, the use of
a high-throughput antibody screen assessing expression of more than 300 cell surface proteins
allowed investigating protein expression with HIV infection success. This combined analysis
showed that the more a gene and the encoded protein correlate with activation, the more they
correlate with permissiveness.
The top candidate markers that correlated with both activation and permissiveness were
further validated as predictors for HIV permissiveness. Expression of cell surface proteins
allowed for sorting live cells from activated CD4+ T-cell populations from different donors.
Individual markers identified cell subpopulations with greater susceptibility to HIV infection
than the general activated cell population. The experimental approach examined the role of
CD25 expression for HIV permissiveness and identified additional surface markers, which
combined with CD25 led to the identification of a unique population of CD4+ T cells that is
highly permissive to HIV. In addition to CD25, the best predictive biomarkers for permissive-
ness were CD298, CD63 and CD317.
CD63 is a tetraspanin associated with the membranes of intracellular vesicles. CD63 can
also be expressed at cell surface, possibly upon T cell activation, thereby promoting sustained
T cell activation and cell proliferation [34]. CD63 has been described to participate in HIV
infection in early and late steps of the HIV life cycle, both in macrophages and CD4+ T cells
[35–38]. CD317, also known as BST-2 or tetherin, is a lipid raft associated protein that restricts
HIV infection by retaining nascent virions at the cell surface and preventing their release [39].
CD298 is the beta3 subunit of the Na,K ATPase, known to maintain the electrochemical gradi-
ents of sodium and potassium across the plasma membrane [40]. CD298 has been associated
as regulator of T cell activation independently of the ATPase alpha subunit [41]. Interestingly,
CD298 was shown to be an antagonist of BST-2 by binding and inducing BST-2 degradation
and therefore facilitating HIV replication [42].
The transcriptional profile of CD25highCD298highCD63highCD317high expressing cells
revealed a specific signature as compared to the CD25high cell population, characterized by the
down-regulation of 96 genes, most of which are involved in innate immunity. These results are
consistent with previous model suggesting that activated CD4+ T cells are more permissive to
HIV infection than resting CD4+ T cells in part due to reduced innate immune responses [1].
The specific signature of this cell population highlights the potential of single-cell RNA-seq
analysis as a general pipeline for biomarker identification.
In conclusion, single-cell RNA-seq allowed the investigation of CD4+ T-cell heterogeneity
prior to infection and led to the identification of markers for permissiveness to HIV cellular
infection. Their combined use serves to identify a cellular state that defines the “HIV permissive
cell”. A similar approach should be used to identify the biomarkers of the resting cell predicting
its activation potential, and thus its permissive phenotype. Finally, the relevance of these highly
permissive cells in vivo, i.e. will these cells more likely be infected and then become latent and
contribute to the reservoir or will they more likely die and be depleted, remains to be elucidated.
Materials and methods
Ethics statement
All blood donors have provided written informed consent. All samples were anonymized.
Cell samples, isolation and culture conditions
Peripheral Blood Mononuclear Cells (PBMCs) from different healthy blood donors were puri-
fied by Ficoll gradient separation, using Leucosep tubes (Greiner), followed by CD4+ T cell
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isolation using negative selection and magnetic separation, according to manufacturer’s
instructions (Stemcell Technologies). Total CD4+ T cells were isolated using EasySep Human
CD4+ T Cell Enrichment Kit, naïve cells were isolated using EasySep Human Naïve CD4+ T
Cell Enrichment Kit and memory CD4+ T cells were isolated using Human Memory CD4+ T
Cell Enrichment Kit. Cell enrichment yielded a purity of CD4+T cell populations of up to 96%.
Non-activated CD4+ T cells were maintained in RPMI-1640 culture medium (Gibco) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS). T-cell receptor (TCR)-medi-
ated activation of CD4+ T cells was performed using CD3/CD28 co-stimulation in presence of
IL-2 (100 U/ml, R&D Systems). For this, anti-CD3 antibodies (4 μg) were plated in 1 ml PBS
per well of a 6-well plate and incubated overnight at 4˚C. Wells were washed once with PBS
and cells were added in each well at 2x106 cells/ml in OpTmizer CTS T-Cell Expansion serum-
free medium (Gibco), supplemented with 1 μg/ml anti-CD28 antibodies (BD Biosciences).
Virus production and infection
For the HIV-based lentiviral vector EF1-GFP/VSV-G (named HIV-GFP) production, 2.5
million of HEK293T cells (from [43]) per 10 cm dishes were transfected with 15 μg of
pWPI-EF1α-GFP [44], 10 μg of psPAX2 packaging plasmid (gift from Didier Trono (Addgene
plasmid # 12260)) and 5 μg pMD2G coding for the VSV-G envelope [45], using calcium phos-
phate transfection kit (Life Technologies). HIV-GFP particles were then harvested 48h after
transfection, filtered through 0.45 μm filters and concentrated by filtration on Centricon units
(Centricon Plus-70/100K, Millipore). Replication-competent CXCR4-tropic NLENG1 viruses
were produced by transfecting HEK293T cells with pNLENG1-IRES (gift from David N. Levy,
[46]) using jetPEI (Polyplus transfection), following manufacturer’s instructions and collected
48h later. Of note, NLENG1 derives from pNL4-3 and contains gfp as a fluorescent reporter
gene (eGFP-IRES-nef). Viral titers were measured by HIV-1 p24 Enzyme-linked immunosor-
bent assay (ELISA) kit (Innogenetics).
Primary CD4+ T cells (100,000 cells) were infected by spinoculation (1500 x g, 25˚C, 1h30)
in the presence of 4 μg/ml polybrene with 300 ng of HIV-GFP or 25 ng NLENG1. After spino-
culation cells were washed and maintained for 48h or 72h in culture with OpTmizer CTS
T-Cell Expansion serum-free medium in the presence of 100U/ml of IL-2.
Antibody screen (LEGENDScreen Human Cell Screening)
CD4+ T cells from donor #42 (from a previous study [3]) were TCR-activated for 48h as
described above and infected with HIV-GFP. After 24h of infection, CD4+ T cells were incu-
bated with the LEGENDScreen Human Cell Screening PE-conjugated Antibodies (BioLe-
gend), according to manufacturer’s recommendations. Briefly, 100,000 cells were stained with
each provided PE-antibody for 30 min at 4˚C, according to the manufacturer’s protocol,
washed with PBS-BSA (1%), fixed with 200 μl of CellFIX (BD Biosciences) and analyzed by
FACS Gallios (Beckman Coulter). Marker expression and GFP reporter expression data were
analyzed using FlowJo software (Tree Star).
Flow cytometry analysis of surface markers and cell sorting
CD4+ T cells were collected at 0h, 24h, 48h, and 72h after TCR activation and analyzed by
FACS for longitudinal expression assays. Co-expression analysis of multiple biomarkers was
performed at 48h post-activation only. Briefly 100,000 cells were used for each staining,
washed twice with PBS-BSA, and incubated at 4˚C for 30 min with the different surface anti-
bodies (S7 Table). Cells were then washed twice with PBS-BSA, fixed with CellFIX and
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analyzed by flow cytometry using FACS BD Accuri C6 (BD Biosciences). Data was analyzed
using FlowJo software.
Staining for cell sorting was performed on a cell suspension of 10–40 million CD4+ T cells,
in 250–500 μl of RoboSep buffer (Stemcell Technologies). After cell washing, cells were incu-
bated with the different antibodies (S8 and S9 Tables) at 4˚C for 30 min, washed and resus-
pended in Robosep Buffer (1–2 ml) prior to sorting on MoFlo Astrios (Beckman Coulter Life
Sciences; Flow Sorting Facility, University of Lausanne).
Single-cell RNA-seq
Cells from the two donors (#42 and #123, from a previous study [3]) were TCR-activated as
previously described, and maintained in 2 ml OpTmizer expansion medium with 5% FBS
and100 U/ml IL-2 for 72h. Dead cells were removed by centrifugation on a 3 ml Percoll gradi-
ent at 800 x g for 10 minutes. Cells were washed, counted and resuspended in PBS. Cells were
either used for bulk RNA-Seq or loaded to the Fluidigm C1 platform for single-cell capture
and single-cell RNA-seq library generation according to the manufacturer’s protocol. Briefly, a
cell suspension of approximately 300,000 cells/ml was introduced into the medium size chip
(10–17 μm plate), suitable to capture cells of 10–17 ± 2 μm, and thus able to capture activated
cells (usually ranging from 10 to 13 μm). After cell separation and capture, empty or debris-
occupied wells were identified by microscope visualisation and discarded from subsequent
analysis. cDNA libraries were then produced directly and automatically on the chip with Clon-
tech SMARTer Ultra Low RNA kit for Illumina using manufacturer-provided protocols. Illu-
mina libraries were constructed in 96-well plates using the Illumina Nextera XT DNA Sample
Preparation kit according to a protocol supplied by Fluidigm and sequenced on HiSeq2500
machine (Illumina), with 50 bp paired-end, 14 libraries multiplexed per lane.
Population RNA-seq
RNA from bulk samples was extracted using Illustra RNAspin kit (GE Healthcare). mRNA-Seq
library preparation was performed with TruSeq RNA sample prep kit (Illumina) starting with
capture of polyA-containing transcripts, followed by cluster generation (TruSeq single-end
cluster generation kit, Illumina) and high-throughput sequencing on Illumina HiSeq2500
(Genomics Technology Facility, University of Lausanne). 100 cycles single-end sequencing
was performed for all bulk samples except for the high permissive/low permissive donors that
used 50 cycles paired-end sequencing. Additional bulk samples from resting and activated
CD4+ T cells used in the PCA analysis were from published work [47].
Bioinformatics analysis
Sequenced reads obtained were cleaned before alignment using cutadapt v0.9.5 [48] to remove
the adapter if present at the 3’ end of the read with an overlap between the read and the adapter
equal or higher than 13 bases, and prinseq v0.20 to remove: i) low quality nucleotides at the 30
or 50 end of the reads (PHRED score<6); ii) reads with mean PHRED score lower than 20; iii)
poly-A/T tail with a minimum length of 13 either at the 5’-end or the 3’-end; iv) poly-N tail
with a minimum length of 2 either at the 5’-end or at the 3’-end. Cleaned reads were aligned to
the human reference genome with STAR aligner v2.3.0 [49] using the Ensembl gene GRCh37
release 70 annotation file. RUM aligner [50] was used for the first 8 bulk libraries indicated in
S10 Table. The number of reads per gene was quantified with HTSeq-count v.0.6.1 [51], with
parameters mode = union and type = exon. An average library size of 59,862,736 and
6,618,513 uniquely mapped reads in the bulk and single-cell libraries was obtained respec-
tively. For downstream analysis, log-transformation of gene expression values was performed
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as the log10 of the number of library size-normalized reads per kilobase of exonic sequence. A
pseudo-count of 1 was added previous to the log10 transformation to avoid NA’s: log10
(RPKM59862736/1000000+1). The index of bulk and single-cell RNA-seq libraries, the per-
gene raw read-counts matrix and the described log-transformed matrix are provided in
S10, S11 and S12 Tables. One of the single-cell libraries from the high resistant donor
(“poolT12_2”) appeared as an outlier in initial exploratory analyses and was discarded from
downstream analyses. Analysis of transcriptional heterogeneity across single cells was per-
formed using Sincell Bioconductor package [27]. Differential expression analyses used
DESeq2 bioconductor package [32]. Functional enrichment analysis was performed using
STRING with default parameters [52]. An R script with the code necessary to reproduce all
bioinformatics results and figures is provided as S1 File. Versions of R-packages used are
detailed in at the end of S1 File.
Statistical analysis
Statistical analyses were performed using the Prism software (v6.0aGraphPad). All compari-
sons of HIV permissiveness in non-overlapping subpopulations (single populations or single
and multiple sorting populations) were performed using paired t-test.
To assess the significance of the use of additional markers to CD25, thus comparing nested
subpopulations, we fitted for each selected candidate marker a linear regression model on the
fold-increase observed when adding to the CD25high subpopulation (taken as a basal reference
level) the second marker high, while accounting for the Donor effects in the regression model.
To make the model robust to departures from normality of the residuals distribution, we used
3 alternative transformations of the dependent variable: absolute rank, relative rank within
donor and log-transformation of the fold increase.
Supporting information
S1 Fig. Selection of cell donors for single-cell RNA-seq. The selection of a high and a low
permissive donor was based on permissiveness to HIV-GFP and growth index (cell count on
day 14/cell count on day 7 post-activation). Two donors were selected, identified here as “42”
and “123”, with differences in level of HIV permissiveness (~40% and ~10% GFP+ infected
cells, respectively) while showing similar growth capacity.
(PDF)
S2 Fig. Distribution of pairwise similarities among the whole transcriptome of the individ-
ual cells from a donor. The figure shows the distribution of Spearman correlation values
between the log-transformed gene expression levels of all pairwise comparisons among the
individual cells from the same individual. Gene expression levels are the log10 of the number
of library size-normalized reads per kilobase of exonic sequence (Methods). Distributions have
medians of 0.72 and 0.59 and standard deviations of 0.09 and 0.12 for the high and low permis-
sive donor, respectively (Wilcoxon-rank sum two-sided test p-value < 2.2e-16).
(PDF)
S3 Fig. Hierarchies of the transcriptomes of individual cells. Cell-state hierarchies of the
high permissive (A) and low permissive (B) donors assessed using Sincell Bioconductor pack-
age. Hierarchies are based on the first two dimensions of a PCA performed on the log-trans-
formed gene expression values (Methods) followed by Iterative Mutual Clustering (parameter
k = 4) as described in [27]. Assessment of hierarchies was restricted to the 3558 genes signifi-
cantly variable across individual cells, assessed on the library size normalized read count
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matrix and performing Winsorization as described in http://pklab.med.harvard.edu/scw2014/
subpop_tutorial.html. (C) and (D): Statistical support for the cell-state hierarchies represented
in A and B, respectively. Figures represent the distribution of similarities (Spearman rank cor-
relations; median 0.92 and 0.96 for c and d, respectively) between the reference cell-state hier-
archy and the 100 hierarchies obtained when 100 random sets of 50% of genes are subsampled,
as described in Julia´ et al. 2015 [27].
(PDF)
S4 Fig. Equivalence across the Principal Component Analysis (PCA) axes of single-cell
RNA-seq libraries. (A) Principal component analysis of the log-transformed gene expression
levels of 85 and 81 single-cell RNA-seq libraries from the high permissive (black) and low per-
missive (red) donors. Gene expression levels are the log10 of the number of library size-nor-
malized reads per kilobase of exonic sequence (Methods). (B) Correlation between the PC2
cell coordinates from Fig 1B and the PC1 cell coordinates from S4 Fig Panel A (Pearson corre-
lation = 0.9994).
(PDF)
S5 Fig. Clustering and heatmap of the expression levels across individual cells from high
(left) and low (right) permissive donors does not cluster single cells according to cell sub-
population or innate immunity gene expression. (A) 63 genes (S1 Table) commonly used to
classify CD4+ T cell subpopulations, including helper (Th1, Th2, Th17), regulatory (T-reg),
and memory (Effector and Central memory) CD4+ T cells, and (B) 1503 innate immunity
genes as described in previous work [19]. Single cell samples are displayed by columns as
labeled on the bottom, and genes are displayed by rows. Complete hierarchical clustering of
genes and cell samples was based on Spearman correlation of the log10 of the number of
library size-normalized reads per kilobase of exonic sequence (Methods). Color scale indicated
in the legend corresponds to such log-transformed expression levels, ranging from green (low)
to red (high) expression.
(PDF)
S6 Fig. Impact of HIV-GFP infection on marker expression. FACS plots of candidate
marker expression in CD4+ T cells after 48h TCR-activation followed by 24h mock (grey) or
HIV-GFP (green) infection. This figure is representative of 3 independent experiments.
(PDF)
S7 Fig. Gating strategy for FACS sorting. (A) Gates defining high and low expressing
markers were set on the total population. When the population was clearly separated in two
subpopulations, the gates were placed according to the medium-high population density cor-
responding to the red-yellow areas (example, top panel with CD25). When the population was
homogenous, the gates were placed to the extreme expression levels, corresponding to low
population density and thus outside the red-yellow area (example, lower panel with CD317).
(B) The gates set on the total population were used for successive sorting with the 4 top candi-
date markers.
(PDF)
S8 Fig. Expression of selected markers in CD4+ T cells over time upon TCR activation. The
expression of the selected markers was followed by surface staining and FACS analysis before
and 1, 2, 3 and 4 days after TCR activation. Each graph indicates the percentage of marker
expression (black) and the Mean Fluorescence intensity (MFI, orange). The last graph shows
the viability of cells from three independent donors and their mean (black line). Error bars
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indicate SEM and data shown is from 3 independent experiments with 3 different donors.
(PDF)
S9 Fig. Co-expression of selected markers with CD25. Columns left panels: FACS plots
showing the co-expression of selected markers with CD25 in CD4+ T cells after 48h post-acti-
vation. Columns right panels: Pearson correlation of the corresponding FACS plot (marker
versus CD25).
(PDF)
S10 Fig. Enrichment of permissiveness in sorted cell subpopulations. Fold-increase of per-
missive cells compared to unsorted cells after use of a second marker (CD25highMarkerhigh) to
the CD25high populations for the 4 donors evaluated in Fig 4B. The increase in permissiveness
to HIV observed in CD25highMRKhigh populations as compared to CD25high was evaluated in
S3 Table.
(PDF)
S11 Fig. Enrichment in HIV permissiveness is not dependent on the memory or naïve
lineage. Naïve and memory CD4+ T cell populations were purified from PBMCs by negative
selection, and cell phenotype was confirmed by FACS analysis on CD45RA (naïve cells) or
CD45RO (memory cells). Cells from the two different subsets were then activated for 48h and
infected with HIV-GFP. After 24h, staining and FACS analysis were performed to evaluate the
co-expression of GFP and the different markers in naïve (top panel) and memory cells (right
panel). This figure is representative of 3 independent experiments.
(PDF)
S12 Fig. Co-expression of the top selected markers. (A) FACS plots showing co-expression
of selected markers, two by two in CD4+ T cells after 48h post-activation. (B) Co-expression of
the 4 selected markers (CD25high, CD298high, CD63high, CD317high).
(PDF)
S13 Fig. Enrichment of permissiveness in sorted cell subpopulations. Fold-increase of HIV
permissive cells compared to unsorted cells after use of additional markers (Markerhigh) to the
CD25high populations for the donors evaluated in Fig 5A (left panel) and Fig 5B (right panel).
The increase in permissiveness to HIV of CD25high cells as a function of the number of addi-
tional MRKhigh populations was statistically significant in both experiments (S4 Table).
(PDF)
S14 Fig. Cell selection with additional candidate markers further improves the capture of
the highest permissive cells. CD4+ T cells were TCR-stimulated for 48h and FACS sorted
sequentially for CD25high, CD298high, CD63high, CD317high and CD2high. The sorted popula-
tions were then transduced with HIV-GFP (EF1-GFP) (A) or CXCR-4 tropic NLENG1 (B),
and HIV permissiveness was assessed by FACS. Values correspond to GFP (%) fold increase as
compared to unsorted population. Error bars indicate SEM and data shown is from 3 indepen-
dent experiments with 3 different donors.
(PDF)
S15 Fig. Heatmap clustering of the 5 prototypical HIV restriction factors across different
sorted subpopulations. Complete hierarchical clustering of genes and cell samples was based
on Pearson correlation. Color scale indicated in the legend corresponds to z-scores of gene
expression levels expressed as the log10 of the number of library size-normalized reads per
kilobase of exonic sequence, ranging from green (low) to red (high) expression.
(PDF)
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S1 Table. List of 63 prototypical genes characterizing CD4+ T cell subpopulations and used
for the generation of heatmaps in S5A Fig.
(TXT)
S2 Table. Correlation values represented in Fig 2B. First column in the table corresponds to
the Spearman rank correlation between surface protein expression and GFP levels in individ-
ual cells (see text). Second column corresponds to the correlation of the corresponding gene
expression levels with PC2 in Fig 1B, as determined by single-cell RNA-seq.
(TXT)
S3 Table. Statistical analysis (P-values) assessing the effect on the fold-increase of permis-
sive cells compared to unsorted cells caused by the addition of a second marker (MRKhigh)
to the CD25high population, as determined by a linear regression model accounting for the
donor effects (S10 Fig). To make the test robust to departures from normality of the residuals
distribution, 3 alternative transformations of the dependent variable were used: absolute rank,
relative rank within donor and log-transformation of the fold increase.
(XLSX)
S4 Table. Statistical analysis (P-values) assessing the effect on the fold-increase of permis-
sive cells compared to unsorted cells as a function of the number of additional activation
markers used on top of CD25high (i.e. 1, 2 or 3 markers), as determined by a linear regres-
sion model accounting for the donor effects (S13 Fig). To make the test robust to departures
from normality of the residuals distribution, 3 alternative transformations of the dependent
variable were used: absolute rank, relative rank within donor and log-transformation of the
fold increase. The p-values were significant (p-value<5e-03) in both experiments under the 3
transformations evaluated.
(XLSX)
S5 Table. 96 genes differentially expressed between sorted CD25high and CD25highMR-
K3high (CD25highCD298highCD63highCD317high) subpopulations (fold change higher or
lower than 2 and adjusted p-value of < 0.001; DESeq2 test).
(TXT)
S6 Table. Functional enrichment results of the 96 differentially expressed genes reported
in S5 Table. Enrichment analysis was performed using STRING [52] with default parameters
and the whole human genome as a reference background.
(XLS)
S7 Table. List of antibodies used for flow cytometry for screening validation of the candi-
date markers (Fig 2C).
(XLSX)
S8 Table. List of antibodies used for FACS sorting of single and CD25highMRK sortings
candidate markers (Figs 3B and 4B).
(XLSX)
S9 Table. List of antibodies used for FACS sorting of the four best candidate markers (Fig
5).
(XLSX)
S10 Table. Index of bulk and single-cell RNA-seq libraries.
(TXT)
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S11 Table. Raw read counts of the RNA-seq libraries included in this work, as described in
S10 Table.
(ZIP)
S12 Table. Gene expression matrix expressed as the log10 of the number of library size-
normalized reads per kilobase of exonic sequence (Methods): log10(RPKM59862736/
1000000+1).
(ZIP)
S13 Table. Gene lengths used in this work for the RPKM assessment.
(TXT)
S14 Table. Mapping between gene Ensembl identifiers, gene names and biotypes used in
this work.
(TXT)
S1 File. R script with the necessary code to reproduce the main figures and tables from the
bioinformatics analysis. Versions of the R-packages used are detailed at the end of S1 File.
(R)
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